The adipose tissue-derived stromal vascular fraction (SVF) is a promising candidate for use in cell therapy and tissue engineering due to its regenerative and immunomodulatory properties. Some therapies are based on using the complete SVF product, whereas others depend on the expansion of adipose-derived stromal cells (ASCs) in culture. The latter application often involves a time delay between adipose tissue harvest and SVF isolation. This study investigated how storage time and temperature affected cell quality and composition. Aliquots of lipoaspirate were stored cold (4°C), at room temperature (18–20°C), or at 37°C. SVF was isolated on sequential time points over a period of 48 h, and the following were assessed: cell viability, vitality, composition, and the proliferative potential of the ASCs. When the lipoaspirate was stored cold, the viability of the SVF remained stable for up to 48 h; however, the vitality of the SVF decreased significantly after 24 h. When stored at higher temperatures (room temperature or 37°C), the vitality of the SVF decreased after 8 h. The ASC fraction in the SVF decreased rapidly after 8 h when stored at higher temperatures, whereas this change was delayed significantly when the lipoaspirate was stored cold. Tendencies towards increases in the lag phase, population doubling time (PDt), and time to reach confluency were observed when the lipoaspirate was stored at higher temperatures. The vitality of the SVF was correlated significantly with the time of the lag phase and the time required to reach confluence, whereas no correlation was observed with the PDt. Both prolonged storage time and increased temperature during lipoaspirate storage negatively affected the quality of the obtained SVF. Our results suggest that lipoaspirate should be stored for no longer than 24 h at 4°C to maintain the optimal quality for the isolation of SVF and the expansion of ASCs.

1.
Agostini
F
,
Rossi
FM
,
Aldinucci
D
,
Battiston
M
,
Lombardi
E
,
Zanolin
S
, et al.
:
Improved GMP compliant approach to manipulate lipoaspirates, to cryopreserve stromal vascular fraction, and to expand adipose stem cells in xeno-free media
.
2018
;1–16.
2.
Bourin
P
,
Bunnell
BA
,
Casteilla
L
,
Dominici
M
,
Katz
AJ
,
March
KL
, et al.
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
.
Cytotherapy
.
2013
Jun
;
15
(
6
):
641
8
.
[PubMed]
1465-3249
3.
Carvalho
PP
,
Wu
X
,
Yu
G
,
Dias
IR
,
Gomes
ME
,
Reis
RL
, et al.
The effect of storage time on adipose-derived stem cell recovery from human lipoaspirates
.
Cells Tissues Organs
.
2011
;
194
(
6
):
494
500
.
[PubMed]
1422-6405
4.
Galipeau
J
,
Sensébé
L
.
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
.
Cell Stem Cell
.
2018
Jun
;
22
(
6
):
824
33
.
[PubMed]
1934-5909
5.
Glovinski
PV
,
Herly
M
,
Mathiasen
AB
,
Svalgaard
JD
,
Borup
R
,
Talman
MM
, et al.
Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates
.
Cytotherapy
.
2017
Feb
;
19
(
2
):
222
34
.
[PubMed]
1465-3249
6.
Kilinc
MO
,
Santidrian
A
,
Minev
I
,
Toth
R
,
Draganov
D
,
Nguyen
D
, et al.
The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy
.
Clin Transl Med
.
2018
Feb
;
7
(
1
):
5
.
[PubMed]
2001-1326
7.
Kølle
SF
,
Fischer-Nielsen
A
,
Mathiasen
AB
,
Elberg
JJ
,
Oliveri
RS
,
Glovinski
PV
, et al.
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
.
Lancet
.
2013
Sep
;
382
(
9898
):
1113
20
.
[PubMed]
0140-6736
8.
Kølle
SF
,
Oliveri
RS
,
Glovinski
PV
,
Kirchhoff
M
,
Mathiasen
AB
, et al.
Pooled human lysate versus fetal bovine serum—investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissueederived stem cells intended for clinical use
.
Cytotherapy
.
2013
;
15
:
1
12
.1465-3249
9.
Le
AD
,
Enweze
L
,
DeBaun
MR
,
Dragoo
JL
.
Current Clinical Recommendations for Use of Platelet-Rich Plasma
.
Curr Rev Musculoskelet Med
.
2018
Dec
;
11
(
4
):
624
34
.
[PubMed]
1935-973X
10.
Matsumoto
D
,
Shigeura
T
,
Sato
K
,
Inoue
K
,
Suga
H
,
Kato
H
, et al.
Influences of preservation at various temperatures on liposuction aspirates
.
Plast Reconstr Surg
.
2007
Nov
;
120
(
6
):
1510
7
.
[PubMed]
0032-1052
11.
Ramakrishnan
VM
,
Boyd
NL
.
The Adipose Stromal Vascular Fraction as a Complex Cellular Source for Tissue Engineering Applications
.
Tissue Eng Part B Rev
.
2018
Aug
;
24
(
4
):
289
99
.
[PubMed]
1937-3368
12.
Rasmussen
BS
,
Lykke Sørensen
C
,
Vester-Glowinski
PV
,
Herly
M
,
Trojahn Kølle
SF
,
Fischer-Nielsen
A
, et al.
Effect, Feasibility, and Clinical Relevance of Cell Enrichment in Large Volume Fat Grafting: A Systematic Review
.
Aesthet Surg J
.
2017
Jul
;
37
suppl_3
:
S46
58
.
[PubMed]
1090-820X
13.
Rohban
R
,
Pieber
TR
.
Mesenchymal stem and progenitor cells in regeneration: tissue specificity and regenerative potential
.
Stem Cells Int
.
2017
;
2017
:
5173732
.
[PubMed]
1687-9678
14.
Squillaro
T
,
Peluso
G
,
Galderisi
U
.
Clinical Trials With Mesenchymal Stem Cells: an Update
.
Cell Transplant
.
2016
;
25
(
5
):
829
48
.
[PubMed]
0963-6897
15.
Trounson
A
,
DeWitt
ND
.
Pluripotent stem cells progressing to the clinic
.
Nat Rev Mol Cell Biol
.
2016
Mar
;
17
(
3
):
194
200
.
[PubMed]
1471-0072
16.
Viswanathan
S
,
Shi
Y
,
Galipeau
J
,
Krampera
M
,
Leblanc
K
,
Martin
I
, et al.
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature
.
Cytotherapy
.
2019
Oct
;
21
(
10
):
1019
24
.
[PubMed]
1465-3249
17.
Zhang
Q
,
Fu
L
,
Liang
Y
,
Guo
Z
,
Wang
L
,
Ma
C
, et al.
Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation
.
J Cell Physiol
.
2018
Sep
;
233
(
9
):
6832
40
.
[PubMed]
0021-9541
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.